Midkine Rekombinanter Antikörper
Midkine Rekombinant Antikörper für IHC, IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IHC, IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241880H1
Kat-Nr. : 84815-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84815-1-PBS bindet in IHC, IF/ICC, FC (Intra), Indirect ELISA Midkine und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Midkine fusion protein Ag24547 |
| Vollständiger Name | midkine (neurite growth-promoting factor 2) |
| Berechnetes Molekulargewicht | 16 kDa |
| GenBank-Zugangsnummer | BC011704 |
| Gene symbol | Midkine |
| Gene ID (NCBI) | 4192 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Midkine is a heparin-binding growth factor identified over 20 years ago and enhances the survival, migration and many other activities of target cells. Midkine is rich in both basic amino acids and cysteine, and is not related to most other growth factors/cytokines. It is strongly expressed during embryonic periods, especially at the midgestation stage, and plays important roles in development, especially in neurogenesis. Midkine expression in adult tissue is generally weak or undetectable, and it is induced upon injury and exerts many activities related to tissue repair. The biological activities of midkine in malignant tumors include proliferation, angiogenesis, invasion and metastasis. Various cancers express significantly higher levels of the midkine protein in early stage tumor tissues than in adjacent normal tissue.









